FDA Drug Recalls

Recalls / Class III

Class IIID-0075-2022

Product

Advance Formula Pain Reliever (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets Per Packet, Packaged in 12,000 Packets/Case, PO# 007564-00, Item# 1170, Mfg. for: Advanced First Aid, Baltimore, MD 21237; American Safety & First Aid, Osceola, IN 46561 (Shipping Label)

Affected lot / code info
Lot #: AK-9457, exp. date 22-Jan; AK-9521, exp. date 22-Mar; AK-9959, exp. date 22-Dec; AK-1017, exp. date 23-Jan

Why it was recalled

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Recalling firm

Firm
Ultra Seal Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
521 Main St, N/A, New Paltz, New York 12561-1609

Distribution

Quantity
991,310 tablets
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2021-10-13
FDA classified
2021-10-26
Posted by FDA
2021-11-03
Terminated
2022-03-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0075-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls